About
The HBOT Hub Research Desk is the collective editorial team responsible for sourcing, synthesising, and writing the hyperbaric oxygen therapy content on this site. The team reviews peer-reviewed research across UHMS-approved and research-stage indications, follows regulatory developments at FDA, CMS, and UHMS, and maintains the chamber, condition, and protocol reference libraries. All articles are reviewed for accuracy against primary sources before publication.
Areas of Expertise
- Hyperbaric oxygen therapy
- UHMS indications
- Clinical research synthesis
- Regulatory affairs
Affiliation
HBOT Hub
Authored & Reviewed Articles
- HBOT for Long COVID: What the 2022 Zilberman-Itskovich RCT Found
- Monoplace vs Multiplace Chambers: A Practical Comparison
- 1.3 ATA Soft-Shell HBOT: What the Evidence Actually Shows
- The 14 UHMS-Approved HBOT Indications Explained
- Understanding ATA: The Pressure Unit at the Heart of HBOT
- Chamber Fire Deaths Trigger FDA HBOT Safety Warning in August 2025
- UHMS 15th Edition Indications Manual: What Changed in 2023
- HOT-LoCO Trial: 10 Sessions of HBOT Not Enough for Long COVID
- HBOT Beats Standard Medication for Fibromyalgia After Childhood Trauma
- Harrison 2024: HBOT for Chronic Stroke — The Replication Problem
- HBOT + Exosomes: 2025 Research Opens a New Regenerative Door
- Where HBOT for Veterans Stands in 2025: Federal Bills, VA Pilots, State Programs
- 5 Years After Hachmo: What Happened to HBOT's Telomere Promise
- Aviv Clinics Hits 1,000+ Patients: The Clinical Application of the Efrati Protocol
- The 1.3 ATA Soft-Shell Problem: FDA Status, UHMS Warnings, and the Marketing Gap
Editorial Standards
HBOT Hub follows strict editorial standards for medical content. All articles are sourced from peer-reviewed research, UHMS clinical practice guidelines, FDA regulatory filings, and CMS coverage determinations. Content is reviewed for accuracy against primary sources before publication. Articles are periodically updated to reflect evolving research and regulatory developments. We do not accept paid placement, sponsored content, or product endorsements that would compromise editorial independence.
Corrections & Feedback
We welcome corrections and feedback on our content. If you identify an error, outdated information, or have suggestions for improvement, please contact the editorial team. Documented corrections are implemented within 7 days of verification and noted in the article's revision history.